Get the latest market trends in your inbox

Stay on top of the latest market trends and economic insights with the Axios Markets newsletter. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Minneapolis-St. Paul

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa-St. Petersburg news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa-St. Petersburg

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Screenshot: Gopro.com

Two of the leaders in the action camera world, GoPro and personal drone maker Skydio, unveiled new products Tuesday, aiming to woo new buyers and convince existing owners to upgrade.

The big picture: But whereas once upon a time the biggest issues with such cameras were things like battery life and ease-of-use, the category is now bumping into a new, possibly tougher problem: these cameras are great when you're scaling Half Dome or snorkeling in Maui, but most of our lives just don't pack in enough action to justify such a camera.

Driving the news:

  • GoPro unveiled 2 new models, the $399 Hero8 Black and $499 Hero8 Max, waterproof action cameras which feature the ability to connect accessories directly without separate mounting hardware. The Max version functions as both a traditional action camera and, thanks to dual lenses, a 360-degree recording device.
  • Drone maker Skydio introduced the second version of its owner-following drone, improving the size, range, battery life, camera and other features all with a lower starting price — $999 sans controller. (The Verge has a detailed hands-on here.)

The bottom line: I aspire in the coming year to have enough action to justify the purchase of a GoPro, maybe even the Max. Skydio will probably have to wait at least another year, though that doesn't mean I don't want to try it out, too — especially since I am so bad at flying traditional drones.

Go deeper

Cold December as safety nets expire

Illustration: Sarah Grillo/Axios

Safety nets are likely to be yanked from underneath millions of vulnerable Americans in December, as the coronavirus surges.

Why it matters: Those most at risk are depending on one or more relief programs that are set to expire, right as the economic recovery becomes more fragile than it's been in months.

15 hours ago - Health

Food banks feel the strain without holiday volunteers

People wait in line at Food Bank Community Kitchen on Nov. 25 in New York City. Photo: Michael Loccisano/Getty Images for Food Bank For New York City

America's food banks are sounding the alarm during this unprecedented holiday season.

The big picture: Soup kitchens and charities, usually brimming with holiday volunteers, are getting far less help.

17 hours ago - Health

AstraZeneca CEO: "We need to do an additional study" on COVID vaccine

Photo: Pavlo Gonchar/SOPA Images/LightRocket via Getty Images

AstraZeneca CEO Pascal Soriot said on Thursday the company is likely to start a new global trial to measure how effective its coronavirus vaccine is, Bloomberg reports.

Why it matters: Following Phase 3 trials, Oxford and AstraZeneca said their vaccine was 90% effective in people who got a half dose followed by a full dose, and 62% effective in people who got two full doses.